Molecular networks in drug discovery

Area of Science:

• Biomedical Science
• Computational Biology
• Drug Discovery

Background:

• Global drug discovery spending is rising, yet new drug approval rates are falling due to toxicity and side effects.
• The postgenomic era provides vast biomedical data, revealing complex drug-target interactions and compensatory pathways.
• Traditional drug discovery faces challenges, necessitating innovative approaches to improve efficacy and safety.

Purpose of the Study:

• To introduce polypharmacology as a strategy to enhance drug discovery and development.
• To explore the application of molecular networks and in silico techniques in polypharmacology.
• To present recent advancements in predicting polypharmacology and molecular network analysis.

Main Methods:

• Utilizing cheminformatics, bioinformatics, and systems biology to study molecular networks.
• Employing in silico techniques, including structure- and ligand-based approaches, for prediction.
• Analyzing molecular networks to identify multitarget drug candidates.

Main Results:

• Polypharmacology, by targeting multiple pathways, can mitigate toxicity and adverse drug reactions.
• In silico methods aid in predicting drug toxicity and side effects early in development.
• Multitarget drugs have shown success in treating complex diseases like cancer and mood disorders.

Conclusions:

• Polypharmacology integrated with molecular network technology represents the next generation of therapeutics.
• Informatics-driven approaches are crucial for designing safer drugs with reduced off-target effects.
• This review highlights the potential of polypharmacology to revitalize the drug discovery pipeline.